T. Rowe Price Investment Management
TMO icon

T. Rowe Price Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

T. Rowe Price Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.2M Sell
136,654
-1,192,191
-90% -$647M 0.05% 309
2025
Q4 		$770M Buy
1,328,845
+1,270,643
+2,183% +$719M 0.49% 51
2025
Q3 		$28.2M Buy
58,202
+8,285
+17% +$3.86M 0.02% 467
2025
Q2 		$20.2M Sell
49,917
-1,892,828
-97% -$791M 0.01% 499
2025
Q1 		$967M Sell
1,942,745
-1,141,155
-37% -$618M 0.64% 32
2024
Q4 		$1.6B Buy
3,083,900
+1,433,444
+87% +$788M 0.99% 16
2024
Q3 		$1.02B Buy
1,650,456
+320,020
+24% +$189M 0.62% 42
2024
Q2 		$736M Buy
1,330,436
+501,370
+60% +$287M 0.46% 65
2024
Q1 		$482M Buy
829,066
+823,295
+14,266% +$462M 0.29% 94
2023
Q4 		$3.06M Sell
5,771
-2,178,776
-100% -$1.05B ﹤0.01% 538
2023
Q3 		$1.11B Buy
2,184,547
+306,392
+16% +$163M 0.78% 33
2023
Q2 		$980M Sell
1,878,155
-507,729
-21% -$274M 0.67% 35
2023
Q1 		$1.38B Sell
2,385,884
-51,400
-2% -$29M 0.99% 20
2022
Q4 		$1.34B Sell
2,437,284
-749,436
-24% -$397M 1.03% 19
2022
Q3 		$1.62B Buy
+3,186,720
New +$1.78B 1.29% 11

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management's TMO Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 90% in Q1 2026, selling an estimated $647M and leaving 136,654 shares worth $67.2M. The position accounts for 0.05% of the portfolio, ranked #309.

T. Rowe Price Investment Management first reported a position in TMO in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.62B in Q3 2022. 2,595 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • T. Rowe Price Investment Management held 136,654 shares of Thermo Fisher Scientific worth $67.2M as of Q1 2026.
  • T. Rowe Price Investment Management sold 1,192,191 Thermo Fisher Scientific shares in Q1 2026, an estimated $647M.
  • Thermo Fisher Scientific made up 0.05% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #309 holding.
  • T. Rowe Price Investment Management first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 15 quarters since.
  • T. Rowe Price Investment Management's Thermo Fisher Scientific position peaked at $1.62B in Q3 2022.
  • 2,595 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.